Cerebral Glucose Metabolism Changes in Mild Long COVID Patients
Author Information
Author(s): Sakamoto J.S., Lopes-Santos L.E., de Lacerda K.J.C.C., Trevisan A.C., Alexandre-Santos L., Fukumori O.Y., Bellissimo-Rodrigues F., Wichert-Ana L.
Primary Institution: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
Hypothesis
This study investigates the neurological sequelae of COVID-19 by assessing cerebral glucose metabolism in patients with mild long COVID.
Conclusion
The study found no significant glycolytic metabolic changes in patients with mild long COVID, although some patients exhibited areas of hypometabolism and hypermetabolism.
Supporting Evidence
- 22 patients with mild long COVID were compared to 20 healthy volunteers.
- 15 brain regions showed hypometabolism and 11 regions showed hypermetabolism in the mild COVID group.
- The highest rate of hypometabolism was found in the right mesial temporal region, which is important for memory.
- Patients reported cognitive symptoms like forgetfulness and slow reasoning.
- Statistical analysis showed no significant differences in glucose metabolism between groups.
Takeaway
Researchers looked at how the brains of people with mild long COVID use sugar for energy, but they didn't find big differences compared to healthy people.
Methodology
The study used PET/CT scans to assess cerebral glucose metabolism in 22 patients with mild long COVID and 20 healthy controls.
Limitations
The sample size was small, and the software used for analysis compared data with a non-local database, which may limit the findings.
Participant Demographics
22 patients with mild long COVID (4 men, 18 women) aged 18-60 years, and 20 healthy volunteers (7 men, 13 women) in the same age range.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website